Scholarlink

<p>Hydatidiform mole (HM) is driven by aberrant trophoblast proliferation, disrupting embryonic development and leading to pregnancy loss with increased risk of malignant progression. Despite its clinical significance, the cellular and molecular heterogeneity of HM remains poorly characterized. To address this, we integrated single-nucleus RNA sequencing (snRNA-seq), single-nucleus transposase-accessible chromatin sequencing (snATAC-seq), and spatial transcriptomics to construct a cell-resolved atlas of androgenetic complete HM compared with gestational age-matched controls. The three major trophoblast lineages exhibit distinct differentiation relationships and functional associations: villous cytotrophoblast (VCT) are trophoblast cells with stemness, which can differentiate into hormone-secreting syncytiotrophoblast (SCT) and invasive migratory extravillous trophoblast (EVT). Our findings demonstrate that imprinted genes exhibited cell-type-specific expression patterns in HM, with more pronounced dysregulation in trophoblasts compared to non-trophoblast cells. We identified a deficiency of the progenitor subpopulation VCT1 with inactivation of the stemness-maintaining core transcription factor TP63. The invasive and migratory capacities of EVT were enhanced in HM, along with hyperactivation of the transcription factor MYCN and intensified crosstalk with the immune microenvironment. The SCT-Mature1 compartment displayed impaired maturation and downregulation of placenta-specific hormones, including PSG, CSH, and PAPPA. Machine learning analysis identified <i>RASA1</i> as a novel key regulator characterized by its specific low expression in HM, which was further validated using hTSC (human trophoblast stem cell) to be involved in SCT differentiation. Potential therapeutic targets, such as MYCN and RASA1, and the diagnostic utility of monitoring placenta-specific hormone levels, are expected. Together, our findings establish a framework for understanding HM-specific placental dysfunction and developing future targeted diagnoses and therapies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Single-nucleus multi-omics dissection of dysregulated trophoblast development and disrupted immune microenvironment in complete hydatidiform moles

  • 期刊论文

  • 发表日期：

    2026年2月27日

查看全文
  • Xueyao Chen,
  • Ruijie Yu,
  • Xiaoyuan Gao,
  • Xinwen Zhang,
  • Yuan Gao,
  • Yanli Han,
  • Minghui Lu,
  • Hongqiang Xie,
  • Yang Zou,
  • Peiwen Xu,
  • Zi-Jiang Chen,
  • Yunhai Yu,
  • Han Zhao,
  • Rusong Zhao

摘要

Hydatidiform mole (HM) is driven by aberrant trophoblast proliferation, disrupting embryonic development and leading to pregnancy loss with increased risk of malignant progression. Despite its clinical significance, the cellular and molecular heterogeneity of HM remains poorly characterized. To address this, we integrated single-nucleus RNA sequencing (snRNA-seq), single-nucleus transposase-accessible chromatin sequencing (snATAC-seq), and spatial transcriptomics to construct a cell-resolved atlas of androgenetic complete HM compared with gestational age-matched controls. The three major trophoblast lineages exhibit distinct differentiation relationships and functional associations: villous cytotrophoblast (VCT) are trophoblast cells with stemness, which can differentiate into hormone-secreting syncytiotrophoblast (SCT) and invasive migratory extravillous trophoblast (EVT). Our findings demonstrate that imprinted genes exhibited cell-type-specific expression patterns in HM, with more pronounced dysregulation in trophoblasts compared to non-trophoblast cells. We identified a deficiency of the progenitor subpopulation VCT1 with inactivation of the stemness-maintaining core transcription factor TP63. The invasive and migratory capacities of EVT were enhanced in HM, along with hyperactivation of the transcription factor MYCN and intensified crosstalk with the immune microenvironment. The SCT-Mature1 compartment displayed impaired maturation and downregulation of placenta-specific hormones, including PSG, CSH, and PAPPA. Machine learning analysis identified RASA1 as a novel key regulator characterized by its specific low expression in HM, which was further validated using hTSC (human trophoblast stem cell) to be involved in SCT differentiation. Potential therapeutic targets, such as MYCN and RASA1, and the diagnostic utility of monitoring placenta-specific hormone levels, are expected. Together, our findings establish a framework for understanding HM-specific placental dysfunction and developing future targeted diagnoses and therapies.